These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25686176)

  • 1. Rethinking the use of physicians as hired expert lecturers.
    Mulla K; Shonubi A; Katarey D
    Ann Intern Med; 2015 Feb; 162(4):321. PubMed ID: 25686176
    [No Abstract]   [Full Text] [Related]  

  • 2. Rethinking the use of physicians as hired expert lecturers.
    Khan A
    Ann Intern Med; 2015 Feb; 162(4):321. PubMed ID: 25686177
    [No Abstract]   [Full Text] [Related]  

  • 3. Rethinking the use of physicians as hired expert lecturers.
    Garnick MB; Balter W
    Ann Intern Med; 2015 Feb; 162(4):320-1. PubMed ID: 25686175
    [No Abstract]   [Full Text] [Related]  

  • 4. Rethinking the use of physicians as hired expert lecturers--response.
    Avorn J
    Ann Intern Med; 2015 Feb; 162(4):321-2. PubMed ID: 25686178
    [No Abstract]   [Full Text] [Related]  

  • 5. Rethinking the use of physicians as hired expert lecturers.
    Avorn J
    Ann Intern Med; 2014 Sep; 161(5):363-4. PubMed ID: 25178570
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug firms cut doctors' fees for drug talks.
    McCarthy M
    BMJ; 2014 Mar; 348():g2021. PubMed ID: 24607478
    [No Abstract]   [Full Text] [Related]  

  • 7. Following the script: how drug reps make friends and influence doctors.
    Fugh-Berman A; Ahari S
    PLoS Med; 2007 Apr; 4(4):e150. PubMed ID: 17455991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disclosure UK: transparency should no longer be an optional extra.
    Adlington K; Godlee F
    BMJ; 2016 Jul; 354():i3730. PubMed ID: 27383187
    [No Abstract]   [Full Text] [Related]  

  • 9. US intends to publish drug company payments to doctors from October despite calls for delay.
    McCarthy M
    BMJ; 2014 Sep; 349():g5693. PubMed ID: 25227737
    [No Abstract]   [Full Text] [Related]  

  • 10. Disclosure UK website gives "illusion of transparency," says Goldacre.
    Kmietowicz Z
    BMJ; 2016 Jul; 354():i3760. PubMed ID: 27384062
    [No Abstract]   [Full Text] [Related]  

  • 11. GMC says it can't force doctors to disclose payments from drug companies.
    Torjesen I
    BMJ; 2016 Jul; 354():i3806. PubMed ID: 27390102
    [No Abstract]   [Full Text] [Related]  

  • 12. Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies.
    Spelsberg A; Prugger C; Doshi P; Ostrowski K; Witte T; Hüsgen D; Keil U;
    BMJ; 2017 Feb; 356():j337. PubMed ID: 28174182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personal effects. Can emotive marketing through relationships influence rational doctors' prescriptions?
    Srivastava RK
    Mark Health Serv; 2007; 27(4):29-32. PubMed ID: 18186452
    [No Abstract]   [Full Text] [Related]  

  • 14. Kissing goodbye to key opinion leaders.
    Moynihan RN
    Med J Aust; 2012 Jun; 196(11):671. PubMed ID: 22708752
    [No Abstract]   [Full Text] [Related]  

  • 15. [Not Available].
    Luthy C
    Rev Med Suisse; 2016 Aug; 12(527):1395. PubMed ID: 28671796
    [No Abstract]   [Full Text] [Related]  

  • 16. Key opinion leaders: used as a marketing tool by drug companies.
    Prescrire Int; 2012 Jun; 21(128):163-5. PubMed ID: 22822596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of physicians targeted by the pharmaceutical industry to participate in e-detailing.
    Alkhateeb FM; Khanfar NM; Doucette WR; Loudon D
    Health Mark Q; 2009; 26(2):98-116. PubMed ID: 19408179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current state of compensation of on-duty and on-call urologists in France: a study from AFUF].
    Dariane C; Rizk J; Meyer F; Audenet F; Brichart N; Capon G; Fiard G; Lebdai S; Madec FX; Maurin C; Murez T; Sanson S; Tanchoux C; Terrasa JB; Thibault F; Terrier JE
    Prog Urol; 2014 Jun; 24(7):456-62. PubMed ID: 24861686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time Running Out for Physicians to Review Open Payments Data.
    Am Fam Physician; 2015 May; 91(9):598. PubMed ID: 27489895
    [No Abstract]   [Full Text] [Related]  

  • 20. Act II of the Sunshine Act.
    Pham-Kanter G
    PLoS Med; 2014 Nov; 11(11):e1001754. PubMed ID: 25369363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.